HSTMHealthStream, Inc.
Is the price fair?
Neither cheap nor expensive: nothing decisive, though modest expectations priced in.
Priced for ~1% a year FCF growth. The price demands less than its three-year revenue growth of 5% a year, expectations look modest.
In its normal range: P/E 45.1 vs a 55.8 median over 41 quarters (−19% vs median).
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What HSTM's price assumes
HealthStream, Inc. trades at 45.1× earnings against 45.1× for the median Health Information Services name, cheaper than its own group.
Trailing P/E · Health Information Services median 45.1 · cheaper than the typical name in its group
- Free cash flow yield
- 7.3%
Free cash flow yield · Health Information Services median 6.3%
- Growth the price implies
- +0.53%
Growth the price implies · The price pays for +0.53% free cash flow growth a year for a decade; the business has delivered +14% a year over the last three.
Details›
- Healthcare median P/E509 names
- 26.0
- Health Information Services median P/E25 names
- 45.1
- Free cash flow, trailing twelve months
- $70M
- Market capitalisation
- $950M
- 3-year revenue growth
- +5.4%
- 3-year free cash flow growth
- +14%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $29.77 |
| Its own P/E history, median | $40.17 |
| Its own P/E history, upper quartile | $69.95 |
| 52-week range | $19.82 – $32.51 |
| Today | $32.51 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Health Information Services
Ranks #3 of 20 by RyuScore